Baidu
map

Sci Rep:反复膀胱注射富血小板血浆可改善难治性间质性膀胱炎患者的症状和改变泌尿功能蛋白

2020-10-04 AlexYang MedSci原创

反复膀胱注射自体富含血小板的血浆(PRP)可以改善间质性膀胱炎/膀胱疼痛综合征(IC/BPS)患者的症状;然而,该疗法有效性的客观证据依旧缺乏。

反复膀胱注射自体富含血小板的血浆(PRP)可以改善间质性膀胱炎/膀胱疼痛综合征(IC/BPS)患者的症状;然而,该疗法有效性的客观证据依旧缺乏。

最近,有研究人员调查了PRP治疗后泌尿标志物的变化。40名常规治疗难治的IC/BPS患者,每月4次注射PRP;使用10 mL PRP溶液,血小板浓度为外周血血小板浓度的2.5倍。研究人员在在基线和第4次PRP注射时评估了13种功能蛋白、生长因子和细胞因子的尿液水平。临床参数包括视觉模拟量表(VAS)疼痛评分、每日尿频、夜尿发作、功能性膀胱容量和整体反应评估(GRA)。研究发现,治疗后GRA和症状评分显著下降。在GRA≥2的患者中,在第1个月和3个月的第四次PRP注射后成功率分别为70.6%和76.7%。VAS疼痛评分、频率、夜尿次数均有明显下降(P<0.05)。治疗后尿中神经生长因子、基质金属蛋白酶-13、血管内皮生长因子水平均显著下降(分别为p=0.043、p=0.02、p=0.000);而第4次PRP治疗时血小板衍生生长因子-AB较基线显著增加(p=0.004)。

PRP给药后泌尿标记的变化和与临床改善的相关性

最后,研究人员指出,反复膀胱注射PRP能显著改善IC/BPS患者的症状,并伴随着相关生物标志物水平的变化。

原始出处:

Yuan-Hong Jiang, Yuh-Chen Kuo, Jia-Fong Jhang et al. Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis. Sci Rep. Sep 2020

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719446, encodeId=4bdb1e19446a3, content=<a href='/topic/show?id=622c9e2980d' target=_blank style='color:#2F92EE;'>#间质性膀胱炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97298, encryptionId=622c9e2980d, topicName=间质性膀胱炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84a132724427, createdName=lixiao3337, createdTime=Thu Oct 15 18:04:49 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815827, encodeId=9546181582e68, content=<a href='/topic/show?id=82e99e291b0' target=_blank style='color:#2F92EE;'>#间质性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97291, encryptionId=82e99e291b0, topicName=间质性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Mon Feb 01 10:04:49 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811949, encodeId=18141811949bd, content=<a href='/topic/show?id=5ab78905623' target=_blank style='color:#2F92EE;'>#血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89056, encryptionId=5ab78905623, topicName=血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sat Jun 26 23:04:49 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340363, encodeId=088713403635f, content=<a href='/topic/show?id=26bd465e2e3' target=_blank style='color:#2F92EE;'>#富血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46572, encryptionId=26bd465e2e3, topicName=富血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Tue Oct 06 05:04:49 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528697, encodeId=1eee152869efe, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Tue Oct 06 05:04:49 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1719446, encodeId=4bdb1e19446a3, content=<a href='/topic/show?id=622c9e2980d' target=_blank style='color:#2F92EE;'>#间质性膀胱炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97298, encryptionId=622c9e2980d, topicName=间质性膀胱炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84a132724427, createdName=lixiao3337, createdTime=Thu Oct 15 18:04:49 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815827, encodeId=9546181582e68, content=<a href='/topic/show?id=82e99e291b0' target=_blank style='color:#2F92EE;'>#间质性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97291, encryptionId=82e99e291b0, topicName=间质性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Mon Feb 01 10:04:49 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811949, encodeId=18141811949bd, content=<a href='/topic/show?id=5ab78905623' target=_blank style='color:#2F92EE;'>#血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89056, encryptionId=5ab78905623, topicName=血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sat Jun 26 23:04:49 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340363, encodeId=088713403635f, content=<a href='/topic/show?id=26bd465e2e3' target=_blank style='color:#2F92EE;'>#富血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46572, encryptionId=26bd465e2e3, topicName=富血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Tue Oct 06 05:04:49 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528697, encodeId=1eee152869efe, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Tue Oct 06 05:04:49 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1719446, encodeId=4bdb1e19446a3, content=<a href='/topic/show?id=622c9e2980d' target=_blank style='color:#2F92EE;'>#间质性膀胱炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97298, encryptionId=622c9e2980d, topicName=间质性膀胱炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84a132724427, createdName=lixiao3337, createdTime=Thu Oct 15 18:04:49 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815827, encodeId=9546181582e68, content=<a href='/topic/show?id=82e99e291b0' target=_blank style='color:#2F92EE;'>#间质性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97291, encryptionId=82e99e291b0, topicName=间质性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Mon Feb 01 10:04:49 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811949, encodeId=18141811949bd, content=<a href='/topic/show?id=5ab78905623' target=_blank style='color:#2F92EE;'>#血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89056, encryptionId=5ab78905623, topicName=血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sat Jun 26 23:04:49 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340363, encodeId=088713403635f, content=<a href='/topic/show?id=26bd465e2e3' target=_blank style='color:#2F92EE;'>#富血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46572, encryptionId=26bd465e2e3, topicName=富血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Tue Oct 06 05:04:49 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528697, encodeId=1eee152869efe, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Tue Oct 06 05:04:49 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1719446, encodeId=4bdb1e19446a3, content=<a href='/topic/show?id=622c9e2980d' target=_blank style='color:#2F92EE;'>#间质性膀胱炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97298, encryptionId=622c9e2980d, topicName=间质性膀胱炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84a132724427, createdName=lixiao3337, createdTime=Thu Oct 15 18:04:49 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815827, encodeId=9546181582e68, content=<a href='/topic/show?id=82e99e291b0' target=_blank style='color:#2F92EE;'>#间质性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97291, encryptionId=82e99e291b0, topicName=间质性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Mon Feb 01 10:04:49 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811949, encodeId=18141811949bd, content=<a href='/topic/show?id=5ab78905623' target=_blank style='color:#2F92EE;'>#血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89056, encryptionId=5ab78905623, topicName=血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sat Jun 26 23:04:49 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340363, encodeId=088713403635f, content=<a href='/topic/show?id=26bd465e2e3' target=_blank style='color:#2F92EE;'>#富血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46572, encryptionId=26bd465e2e3, topicName=富血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Tue Oct 06 05:04:49 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528697, encodeId=1eee152869efe, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Tue Oct 06 05:04:49 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1719446, encodeId=4bdb1e19446a3, content=<a href='/topic/show?id=622c9e2980d' target=_blank style='color:#2F92EE;'>#间质性膀胱炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97298, encryptionId=622c9e2980d, topicName=间质性膀胱炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84a132724427, createdName=lixiao3337, createdTime=Thu Oct 15 18:04:49 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815827, encodeId=9546181582e68, content=<a href='/topic/show?id=82e99e291b0' target=_blank style='color:#2F92EE;'>#间质性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97291, encryptionId=82e99e291b0, topicName=间质性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Mon Feb 01 10:04:49 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811949, encodeId=18141811949bd, content=<a href='/topic/show?id=5ab78905623' target=_blank style='color:#2F92EE;'>#血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89056, encryptionId=5ab78905623, topicName=血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sat Jun 26 23:04:49 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340363, encodeId=088713403635f, content=<a href='/topic/show?id=26bd465e2e3' target=_blank style='color:#2F92EE;'>#富血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46572, encryptionId=26bd465e2e3, topicName=富血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Tue Oct 06 05:04:49 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528697, encodeId=1eee152869efe, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Tue Oct 06 05:04:49 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2020-10-06 freve

相关资讯

细胞中的这个“小物体”,99%的人没见过……

患者于消化科门诊就诊,女性,48岁,初步诊断为消化不良

J Gastroenterology: 血管性血友病因子抗原与血小板比率(VITRO)评分可预测肝硬化患者的肝失代偿和死亡率

血管性血友病因子与血小板的比例(VITRO)反映了肝硬化患者肝纤维化和门脉高压的严重程度,因此可能具有预后价值。

Blood:COVID-19感染患者的血小板基因表达和功能的改变

SARS-CoV-2诱导血小板基因表达和功能发生明显改变;血小板高反应性可能通过增加血小板-血小板和血小板-白细胞相互作用来促进COVID-19的病理生理。

Blood:重度COVID-19患者的血小板激活和血小板-单核细胞聚集形成触发组织因子表达

在COVID-19重症患者中,血小板活化和血小板单核细胞聚集形成增加与预后不良有关;重症COVID-19患者的血小板可通过P-选择素和整合素αIIb/β3信号通路诱导单核细胞组织因子表达。

Blood:血小板-VWF通过刺激Tie-2防止白细胞外渗时血浆渗漏

血小板通过与内皮VWF结合并释放Angpt1,阻止中性粒细胞穿出血管时血浆渗漏。 血小板释放的Angpt1刺激内皮细胞Tie-2,从而激活可增强皮质肌动蛋白束的GEF FGD5。

Baidu
map
Baidu
map
Baidu
map